Presentation THT 2024 Reducing Congestion by Removing Fluid From the Interstitium Presenter: William T. Abraham March 04, 2024
Presentation THT 2024 Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins Presenter: Ulrich P. Jorde March 04, 2024
Presentation THT 2024 Early Experience With Devices That Increase Kidney Perfusion From the Aorta Presenter: Jennifer A. Cowger March 04, 2024
Presentation THT 2024 Biomarkers of Congestion: Utility in Clinical Practice and Clinical Trials Presenter: James Januzzi March 04, 2024
Presentation THT 2024 Contemporary Pharmacological Therapies for Acute Heart Failure Presenter: Wilfried Mullens March 04, 2024
News Features THT 2023 The Promise of AI for Improving Health Equity in Heart Failure Todd Neale April 04, 2023
News Conference News THT 2023 More Early Insights Into Interatrial Shunts in HF, but Little to Focus the Field Shelley Wood March 24, 2023
News Conference News THT 2023 REDUCE LAP-HF II Subanalysis Makes the Case for Invasive Exercise Tests Yael L. Maxwell March 22, 2023
Presentation THT 2023 TMVR Clinical Trials: Ready for Prime Time or Stuck in the Mud? Presenter: Martin Leon March 22, 2023
Presentation THT 2023 FDA Guidance on Meaningful Representation in Clinical Trials Presenter: Bram Zuckerman March 20, 2023
News Conference News THT 2022 Probe Beyond Ejection Fraction to Understand and Manage HFpEF L.A. McKeown February 07, 2022
Presentation THT 2022 Clinical Trials During COVID-19: Innvestigator Perspective Presenter: Scott Solomon February 02, 2022
Presentation THT 2022 Heart Failure Trials in the Modern Era: Where Are We Going? Presenter: Andrew Farb February 02, 2022
News Conference News THT 2022 REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF Shelley Wood February 01, 2022
Presentation THT 2022 Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines Presenter: Milton Packer February 01, 2022
Presentation THT 2022 Omecamtiv Mecarbil - Is It More Effective in Low EFs Presenter: John Teerlink February 01, 2022
Presentation THT 2022 Secubitirl-Valsartan Across the Spectrum of EFs Presenter: Scott Solomon February 01, 2022
Presentation THT 2022 SGLT2 Inhibitors: What the Clinician Should Know Presenter: Stefan Anker February 01, 2022